Financial Statements

Amedisys, Inc. (AMED)


+0.56 (+0.73%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) 639430246120-
Net Income 119209184127119
Stock Dividends ----0
Dividend Paid -----
Retained Earnings 758639430246120

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 1201172829,449-
Annual Depreciation 5994-29,41329,456
Capital Expenditure -6-6-5-8-7
Net PPE 1191201172829,449

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -3296599331,196
New Purchases -7-0-1-6-15
Intangible and Goodwill 3296599331,1961,287

Amedisys, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Amedisys, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.